One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, David J Bloomfield, Charlie Chan, Suzy Cleator, Charlotte E Coles, Ellen Donovan, Helen Fleming, David Glynn, Andrew Goodman, Susan Griffin, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Zohal Nabi, Jaymini Patel, Elinor Sawyer, Navita Somaiah, Isabel Syndikus, Karen Venables, John R Yarnold, Judith M Bliss

Open source

DOI
10.3310/wwbf1044
Published
2023-11
Container
Health Technology Assessment
Publisher
National Institute for Health and Care Research
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3310/wwbf1044,
  title = {One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT},
  author = {Adrian Murray Brunt and Joanne S Haviland and Duncan A Wheatley and Mark A Sydenham and David J Bloomfield and Charlie Chan and Suzy Cleator and Charlotte E Coles and Ellen Donovan and Helen Fleming and David Glynn and Andrew Goodman and Susan Griffin and Penelope Hopwood and Anna M Kirby and Cliona C Kirwan and Zohal Nabi and Jaymini Patel and Elinor Sawyer and Navita Somaiah and Isabel Syndikus and Karen Venables and John R Yarnold and Judith M Bliss},
  year = {2023},
  journal = {Health Technology Assessment},
  doi = {10.3310/wwbf1044},
  url = {https://doi.org/10.3310/wwbf1044}
}

RIS

TY  - JOUR
TI  - One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
AU  - Adrian Murray Brunt
AU  - Joanne S Haviland
AU  - Duncan A Wheatley
AU  - Mark A Sydenham
AU  - David J Bloomfield
AU  - Charlie Chan
AU  - Suzy Cleator
AU  - Charlotte E Coles
AU  - Ellen Donovan
AU  - Helen Fleming
AU  - David Glynn
AU  - Andrew Goodman
AU  - Susan Griffin
AU  - Penelope Hopwood
AU  - Anna M Kirby
AU  - Cliona C Kirwan
AU  - Zohal Nabi
AU  - Jaymini Patel
AU  - Elinor Sawyer
AU  - Navita Somaiah
AU  - Isabel Syndikus
AU  - Karen Venables
AU  - John R Yarnold
AU  - Judith M Bliss
PY  - 2023
JO  - Health Technology Assessment
DO  - 10.3310/wwbf1044
UR  - https://doi.org/10.3310/wwbf1044
ER  - 

APA

Brunt, A. M., Haviland, J. S., Wheatley, D. A., Sydenham, M. A., Bloomfield, D. J., Chan, C., Cleator, S., Coles, C. E., Donovan, E., Fleming, H., Glynn, D., Goodman, A., Griffin, S., Hopwood, P., Kirby, A. M., Kirwan, C. C., Nabi, Z., Patel, J., Sawyer, E., Somaiah, N., Syndikus, I., Venables, K., Yarnold, J. R., & Bliss, J. M. (2023). One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT. Health Technology Assessment. https://doi.org/10.3310/wwbf1044

Source records